Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep;119(3):503-12.
doi: 10.1007/s11060-014-1495-1. Epub 2014 Jul 2.

Medical therapy of gliomas

Manmeet S Ahluwalia  1 , Susan M Chang
Affiliations
Review

Medical therapy of gliomas

Manmeet S Ahluwalia et al. J Neurooncol. 2014 Sep.

Abstract

Medical therapies are an important part of adjunctive therapy for gliomas. In this chapter we will review the chemotherapeutic and targeted agents that have been evaluated in clinical trials in grade II-IV gliomas in the last decade. A number of randomized phase III trials were completed and reported. There has been a clear success in oligodendroglial tumors and low grade glioma. Although some progress has been made in glioblastoma, considerable work involving the multidisciplinary collaboration of basic science, translational and clinical investigators needs to be done to improve the outcome of patients with anaplastic astrocytoma and glioblastoma. In addition, tailoring treatment based on molecular cytogenetic characteristics is a major focus of research into precision based medicine for glioma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest M.S.A. has received research support from Novartis, Boehringer Ingelheim. M.S.A. has served on advisory board for Genentech/Roche. S.M.C. has received research support from Novartis/Schering.

References

    1. Muldoon LL, Soussain C, Jahnke K, et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clin Oncol. 2007;25:2295–2305. - PubMed
    1. Omuro AM, Faivre S, Raymond E. Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther. 2007;6:1909–1919. - PubMed
    1. Chang SM, Lamborn KR, Kuhn JG, et al. Neurooncology clinical trial design for targeted therapies: lessons learned from the North American brain tumor consortium. Neuro-Oncology. 2008;10:631–642. - PMC - PubMed
    1. Huang TT, Sarkaria SM, Cloughesy TF, Mischel PS. Targeted therapy for malignant glioma patients: lessons learned and the road ahead. Neurotherapeutics. 2009;6:500–512. - PMC - PubMed
    1. Shaw EG, Wisoff JH. Prospective clinical trials of intracranial low-grade glioma in adults and children. Neuro-Oncology. 2003;5:153–160. - PMC - PubMed

Publication types

MeSH terms